A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)

Keywords

MedicineEpirubicinFluorouracilMucositisChemotherapyGastroenterologyInternal medicineRegimenStomatitisSurgeryCisplatinChemotherapy regimenCyclophosphamide

Affiliated Institutions

Related Publications

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

Andrew Webb , David Cunningham , J.H. Scarffe +16 more

PURPOSE We report the results of a prospectively randomized study that compared the combination of epirubicin, cisplatin, and protracted venous infusion fluorouracil (5-FU) (ECF...

1997 Journal of Clinical Oncology 871 citations

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

Justin S. Waters , A. Norman , David Cunningham +12 more

We report the final results of a prospectively randomized study that compared the combination of epirubicin, cisplatin and protracted venous infusion fluorouracil (5-FU) (ECF re...

1999 British Journal of Cancer 278 citations

Prospective Randomized Trial Comparing Mitomycin, Cisplatin, and Protracted Venous-Infusion Fluorouracil (PVI 5-FU) With Epirubicin, Cisplatin, and PVI 5-FU in Advanced Esophagogastric Cancer

Paul J. Ross , M. Nicolson , David Cunningham +9 more

PURPOSE: We report the results of a prospectively randomized study that compared the combination of epirubicin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU)...

2002 Journal of Clinical Oncology 481 citations

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

Salah‐Eddin Al‐Batran , Nils Homann , Claudia Pauligk +54 more

Docetaxel-based chemotherapy is effective in metastatic gastric and gastro-oesophageal junction adenocarcinoma. This study reports on the safety and efficacy of the docetaxel-ba...

2019 The Lancet 2355 citations

Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

David Cunningham , William Allum , Sally Stenning +12 more

In patients with operable gastric or lower esophageal adenocarcinomas, a perioperative regimen of ECF decreased tumor size and stage and significantly improved progression-free ...

2006 New England Journal of Medicine 6200 citations

Publication Info

Year: 1994
Type: article
Volume: 5
Issue: 7
Pages: 609-616
Citations: 259
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

259

OpenAlex

Cite This

APA Style

                            
                                
                                    Michael Findlay, 
                                
                                    David Cunningham, 
                                
                                    A. Norman
                                
                                et al.
                            
                            (1994). 
                            A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). 
                            Annals of Oncology
                            , 5
                            (7)
                            , 609-616.
                            https://doi.org/10.1093/oxfordjournals.annonc.a058932
                        

Identifiers

DOI: 10.1093/oxfordjournals.annonc.a058932